Michael W. Nall
2017
In 2017, Michael W. Nall earned a total compensation of $1.1M as President and Chief Executive Officer at Biocept, a 58% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $86,366 |
|---|---|
| Option Awards | $509,476 |
| Salary | $394,631 |
| Stock Awards | $112,500 |
| Other | $36,867 |
| Total | $1,139,840 |
Nall received $509.5K in option awards, accounting for 45% of the total pay in 2017.
Nall also received $86.4K in non-equity incentive plan, $394.6K in salary, $112.5K in stock awards and $36.9K in other compensation.
Rankings
In 2017, Michael W. Nall's compensation ranked 8,356th out of 14,666 executives tracked by ExecPay. In other words, Nall earned more than 43.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,356 out of 14,666 | 43rd |
Division Services | 1,512 out of 2,424 | 38th |
Major group Health Services | 141 out of 224 | 37th |
Industry group Medical And Dental Laboratories | 35 out of 64 | 45th |
Industry Medical Laboratories | 35 out of 64 | 45th |
Source: SEC filing on May 29, 2018.
Nall's colleagues
We found two more compensation records of executives who worked with Michael W. Nall at Biocept in 2017.